Shingles vaccine 'slashes risk of dementia by 17%’

The video explores the potential link between herpes family viruses, particularly herpes zoster, and dementia. It discusses a study comparing the effects of the Shingrix vaccine against the older zoster vaccine on delaying the onset of dementia. The findings suggest that Shingrix may extend the time lived without dementia by an average of 164 days compared to the zoster vaccine, highlighting the significance of this additional time for individuals at risk of developing dementia.

What new insight or understanding did you gain from this video?

Evaluate responses using AI:

OFF